- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.08. | Bristol Myers wins 'milestone' FDA approval of myeloma drug acquired from Celgene | ||
| 14.08. | Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers | ||
| 14.08. | Biotech initiatives pick up as more regions race to become hubs | ||
| 13.08. | New Taiho, Cullinan data heats up lung cancer drug battle | ||
| 13.08. | PTC takes a chance on Sangamo's Fabry disease gene therapy | ||
| 12.08. | Lilly files six lawsuits in bid to shut down 'black market' for retatrutide | ||
| 12.08. | Psychedelics developer Definium scores more positive data for LSD pill | ||
| 12.08. | Silence cashes in on 'differentiated' data; UK reaffirms support for childhood vaccines | ||
| 12.08. | Boulevard starts up with $65M to pursue targeted autoimmune drugs | ||
| 11.08. | Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs | ||
| 11.08. | Chasing Dupixent, a biotech aims to make better antibody drugs for eczema | ||
| 11.08. | Trump signs order seeking to upend childhood vaccine schedule | ||
| 11.08. | Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease | ||
| 11.08. | Vaderis hauls in $152M to test an AKT-targeting drug | ||
| 10.08. | Sionna cystic fibrosis drug fails key trial, removing threat to Vertex | ||
| 10.08. | Jazz to buy rare epilepsy drugmaker in potentially $1.3B deal | ||
| 10.08. | Scribe's Benjamin Oakes on a rare IPO and bringing CRISPR to the masses | ||
| 10.08. | Regulatory operations: The overlooked half of submission readiness | ||
| 07.08. | 'Significant' demand for Revolution drug; Intellia pinpoints liver toxicity culprit | ||
| 07.08. | Latigo IPO raises nearly $350M for pain drug development | ||
| 06.08. | Replimune rebounds to win FDA approval of melanoma drug | ||
| 06.08. | Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M | ||
| 06.08. | Takeda approval ushers in new wave of sleep drugs | ||
| 06.08. | Erica Schwartz confirmed as next CDC director | ||
| 06.08. | With $263M, LifeMine unearths a new drug for organ transplants |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.